Creative Planning
IMUX icon

Creative Planning’s Immunic IMUX Stock Holding History

Creative Planning’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,502
Closed -$38.9K – 4358
2026
Q1 		$38.9K Buy
3,502
+2
+0.1% +$18 ﹤0.01% 4008
2025
Q4 		$18.7K Hold
3,500
– – ﹤0.01% 3850
2025
Q3 		$30.9K Hold
3,500
– – ﹤0.01% 3789
2025
Q2 		$24.4K Hold
3,500
– – ﹤0.01% 3584
2025
Q1 		$38.1K Hold
3,500
– – ﹤0.01% 3367
2024
Q4 		$35K Buy
+3,500
New +$44.1K ﹤0.01% 3289
2017
Q3 		– Sell
-2
Closed -$2K – 2761
2017
Q2 		$2K Hold
2
– – ﹤0.01% 4306
2017
Q1 		$3K Hold
2
– – ﹤0.01% 4163
2016
Q4 		$3K Hold
2
– – ﹤0.01% 4148
2016
Q3 		$4K Hold
2
– – ﹤0.01% 3976
2016
Q2 		$4K Hold
2
– – ﹤0.01% 3747
2016
Q1 		$6K Buy
+2
New +$6.95K ﹤0.01% 3495
2015
Q4 		– Sell
-11
Closed -$18K – 4484
2015
Q3 		$18K Buy
+11
New +$55K ﹤0.01% 2802

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Creative Planning's IMUX Position: Q2 2026 in Review

Creative Planning sold out of Immunic (IMUX) in Q2 2026, closing a stake of 3,502 shares — an estimated $38.9K sold.

Creative Planning first reported a position in IMUX in Q3 2015 and held it in 13 quarters. The position peaked at $38.9K in Q1 2026. 56 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Creative Planning reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • Creative Planning sold 3,502 Immunic shares in Q2 2026, an estimated $38.9K.
  • Creative Planning first reported a position in Immunic in Q3 2015 and held it in 13 quarters.
  • Creative Planning's Immunic position peaked at $38.9K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.